Mechanistically, TGF-β, which is abundantly present in the tumor microenvironment, activates the classical TGF-β/Smad pathway in cells that express CD103, and consequently, transcription of the CD103 encoding gene, itgae, increases [256]. The gene discussed is ITGAE; the disease is neoplasm.